首页> 外文期刊>Vascular pharmacology >Vasorelaxant effect of euxanthone in the rat thoracic aorta.
【24h】

Vasorelaxant effect of euxanthone in the rat thoracic aorta.

机译:硫蒽酮对大鼠胸主动脉的血管舒张作用。

获取原文
获取原文并翻译 | 示例
           

摘要

This study was undertaken to investigate the effect of euxanthone on isolated rat thoracic aorta. Euxanthone concentration-dependently relaxed high K+-induced sustained contractions with IC50 values of 32.28+/-1.73 microM and this inhibition was antagonized by increasing the Ca2+ concentration in the medium. These results indicated that euxanthone may have calcium antagonistic property. Euxanthone also relaxed norepinephrine (NE)-induced sustained contractions with IC50 values of 32.50+/-2.15 microM and this relaxant effect was unaffected by the removal of endothelium or by the presence of propranolol, indomethacin, glibenclamide or N(omega)-nitro-L-arginine. Moreover, euxanthone inhibited both the phasic and tonic contractions induced by NE in a concentration-dependent manner and showed more potent inhibition on phasic contraction (P < 0.01). Pre-treatment with euxanthone inhibited vascular contraction induced by phorbol 12, 13-dibutyrate (PDBu), a protein kinase C (PKC) agonist, in either the presence or absence of Ca2+ in the solution with IC50 values of 20.15+/-1.56 and 18.30+/-1.62 microM, respectively. However, when the tissues were treated with euxanthone after the PDBu-induced contraction had reached a steady state, the tension was not affected by euxanthone. This study also showed that the inhibitory effect of pre-treatment of euxanthone was more potent than the post-treatment after the tension had reached a steady state. These results suggested that the vasorelaxation of euxanthone may be through multiple pathways involved PKC-mediated signal pathway and calcium-independent pathway besides the direct inhibition of calcium influx and its vasorelaxant effect is more active on calcium-independent pathway and more sensitive to the initial stage of contraction.
机译:进行这项研究以研究欧蒽酮对离体大鼠胸主动脉的作用。依硫蒽酮浓度依赖性地放松高K +诱导的持续收缩,IC50值为32.28 +/- 1.73 microM,并且通过增加培养基中的Ca2 +浓度来拮抗这种抑制作用。这些结果表明,硫蒽酮可能具有钙拮抗作用。乙硫蒽酮还缓解了去甲肾上腺素(NE)引起的持续收缩,IC50值为32.50 +/- 2.15 microM,并且该舒张作用不受内皮去除或普萘洛尔,吲哚美辛,格列苯脲或N(ω-硝基)-存在的影响。 L-精氨酸。此外,乙硫蒽酮以浓度依赖的方式抑制NE诱导的相变和强直收缩,并且对相收缩表现出更强的抑制作用(P <0.01)。在溶液中存在或不存在Ca2 +(IC50值为20.15 +/- 1.56)的情况下,用硫蒽酮预处理可抑制蛋白激酶C(PKC)激动剂佛波12、13-丁酸(PDBu)诱导的血管收缩。分别为18.30 +/- 1.62 microM。但是,当PDBu引起的收缩达到稳定状态后,用uxanthone处理组织时,张力不受euxanthone的影响。该研究还表明,在张力达到稳定状态后,乙硫蒽酮预处理的抑制作用比后处理更为有效。这些结果提示,ux蒽酮的血管舒张作用可能是通过PKC介导的信号途径和钙非依赖途径的多种途径,除了直接抑制钙内流外,其血管舒张作用对钙非依赖的途径更活跃,对初始阶段更敏感。收缩。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号